Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
S1 Ep109: Leveraging Surgical Oncology Advances in Colorectal Cancer Care
|
May 13, 2024 |
S1 Ep108: Administering CAR T-Cell Therapy and Bispecific Agents in Nursing Practice
|
May 06, 2024 |
S1 Ep107: Applying Novel Radiotherapy Technology for Brain Tumors and Other Cancers
|
Apr 29, 2024 |
S1 Ep106: Moving The Needle in Lung Cancer Management With Robotic-Assisted Surgery
|
Apr 22, 2024 |
S1 Ep105: Surgeons Talk Key Treatment and Institutional Advances Across Oncology Care
|
Apr 15, 2024 |
S1 Ep104: Finding Ways to Break the Mold in GU Oncology
|
Apr 08, 2024 |
S1 Ep103: Achieving Health Equity in Lung Cancer Surgery
|
Apr 01, 2024 |
S1 Ep102: Updated ASCO Guidelines for Optimal Small Cell Lung Cancer Management
|
Mar 25, 2024 |
S1 Ep101: Creating a First-of-Its-Kind Integrative Oncology Program at City of Hope
|
Mar 18, 2024 |
S1 Ep100: Addressing Rising Cancer Incidence and Burden in Younger Populations
|
Mar 11, 2024 |
S1 Ep99: How to Expand Health Equity in Oncology
|
Mar 04, 2024 |
S1 Ep98: Diane M. Simeone, MD “Thrilled” To Be UCSD Moores Cancer Center Director
|
Feb 26, 2024 |
S1 Ep97: Expert Perspectives on 2024 ASCO GI Cancers Symposium Trial Updates
|
Feb 19, 2024 |
S1 Ep96: Combatting Stigmatization to Increase Lung Cancer Screening Access
|
Feb 12, 2024 |
S1 Ep95: Unraveling Resistance and Heterogeneity in Mantle Cell Lymphoma Management
|
Feb 05, 2024 |
S1 Ep94: SIO/ASCO Guidelines for Integrative Therapies to Manage Anxiety/Depression
|
Jan 29, 2024 |
S1 Ep93: Jyoti S. Mayadev, MD, on Pembrolizumab/CRT FDA Approval in Cervical Cancer
|
Jan 22, 2024 |
S1 Ep92: Managing CDK4/6 Inhibitor, ADC Toxicity in Metastatic Breast Cancer
|
Jan 15, 2024 |
S1 Ep91: HER2CLIMB-02 Trial Shows ‘Interesting Data’ in HER2+ Breast Cancer
|
Jan 09, 2024 |
S1 Ep90: Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
|
Jan 01, 2024 |
S1 Ep89: Expert Discusses Screening Advocacy, AI, and Developments in Breast Cancer
|
Dec 18, 2023 |
S1 Ep88: Joleen Hubbard, MD, Highlights The “Exciting Space” Of Metastatic CRC
|
Dec 11, 2023 |
S1 Ep87: Adapting to a Robotic Workstation for Image-Guided Liver Cancer Surgery
|
Dec 04, 2023 |
S1 Ep86: Tanios S. Bekaii-Saab, MD, Speaks to Expanding Horizons in CRC Treatment
|
Nov 27, 2023 |
S1 Ep85: Multidisciplinary Care and New Treatment Options in CRC
|
Nov 20, 2023 |
S1 Ep84: Multidisciplinary Care, Approval Updates, and Future Research in NSCLC
|
Nov 13, 2023 |
S1 Ep83: Psychosocial Approach to Sexual Dysfunction During and After Cancer Treatment
|
Nov 08, 2023 |
S1 Ep82: Experts Discuss Differences in Radiotherapy Outcomes in BRCA+ Breast Cancer
|
Oct 30, 2023 |
S1 Ep81: Pipeline Perspectives: Fruquintinib in Metastatic Colorectal Cancer
|
Oct 02, 2023 |
S1 Ep80: Navigating the Impact of Chemotherapy Shortages on Cancer Care and Finances
|
Sep 11, 2023 |
S1 Ep79: Frontline Forum: Testing and Targeted Therapy in EGFR Exon20+ NSCLC
|
Sep 04, 2023 |
S1 Ep78: Frontline Forum: Real-World Practice in Newly Diagnosed Multiple Myeloma
|
Aug 14, 2023 |
S1 Ep77: Relapsed/Refractory Multiple Myeloma Trial Updates From ASCO 2023
|
Aug 07, 2023 |
S1 Ep76: Sarcoma Awareness Month 2023 with Brian Van Tine, MD, PhD
|
Jul 31, 2023 |
S1 Ep75: Oncology On-The-Go Podcast: Secondary Cancer Susceptibility in Cancer Survivors
|
Jun 27, 2023 |
S1 Ep74: Oncology On-The-Go Podcast: ASCO 2023 Recap
|
Jun 19, 2023 |
S1 Ep73: Oncology On-The-Go Podcast: Nursing-Led Palliative Care in Advanced Cancer
|
May 15, 2023 |
S1 Ep72: Oncology On-The-Go Podcast: De-escalating Breast Cancer Treatment
|
May 08, 2023 |
S1 Ep71: Oncology-On-The-Go Podcast: Signaling Pathways in Glioblastoma Relapse
|
May 01, 2023 |
S1 Ep70: Oncology On-The-Go Podcast: SGO 2023 Recap
|
Apr 24, 2023 |
S1 Ep69: Oncology On-The-Go Podcast: COVID-19 Vaccination and Cellular Therapy in Cancer
|
Apr 17, 2023 |
S1 Ep68: Oncology On-The-Go Podcast: Multiple Myeloma Outcome Disparities, Trial Access
|
Apr 12, 2023 |
S1 Ep67: Oncology On-The-Go Podcast: Integrative and Palliative Kidney Cancer Care
|
Mar 28, 2023 |
S1 Ep66: Oncology On-The-Go Podcast: Time to Treatment for Breast Cancer in Rural Populations
|
Feb 27, 2023 |
S1 Ep65: Oncology On-the-Go Podcast: Sacituzumab Govitecan for HR+/HER2– Advanced Breast Cancer
|
Feb 20, 2023 |
S1 Ep64: Oncology Peer Review On-The-Go Podcast: Cervical Cancer Screenings/Survival in Those 65+ Years
|
Feb 02, 2023 |
S1 Ep63: Oncology Peer Review On-The-Go: Integrative Oncology in Young Population with Breast Cancer
|
Jan 16, 2023 |
S1 Ep62: Oncology Peer Review On-The-Go: Experts Share Multidisciplinary Takeaways From 2022 SABCS
|
Dec 26, 2022 |
S1 Ep61: Oncology Peer Review On-The-Go: Minimal Residual Disease–Directed Adjuvant Therapy for Patients With Early-Stage Colon Cancer
|
Nov 14, 2022 |
S2 Ep26: Between the Lines Podcast: Tazemetostat in Relapsed/Refractory Follicular Lymphoma
|
Nov 03, 2022 |
S1 Ep60: Oncology Peer Review On-The-Go: Cancer Pain and Opioid Use Disorder
|
Oct 31, 2022 |
S1 Ep59: Oncology Peer Review On-The-Go: Cancer-Related Fatigue Outcome Measures in Integrative Oncology
|
Sep 19, 2022 |
S1 Ep58: Oncology Peer Review On-The-Go: Current Treatments in Peripheral T-cell Lymphoma
|
Aug 22, 2022 |
S1 Ep56: Oncology Peer Review On-The-Go: Current Treatments in Marginal Zone Lymphoma
|
Aug 09, 2022 |
S1 Ep55: Oncology Peer Review On-The-Go: The Prognostic Significance of Peripheral Blood Biomarkers in Patients With Advanced Non–Small Cell Lung Cancer Treated With Pembrolizumab: A Clinical Study
|
Jul 25, 2022 |
S1 Ep54: Oncology Peer Review On-The-Go: Focus of Current and Emerging Therapies in Follicular Lymphoma
|
Jul 11, 2022 |
S1 Ep57: Oncology Peer Review On-The-Go: Paolo Tarantino, MD, and Sara Tolaney, MD, Review Data in the Treatment of Breast Cancer at 2022 ASCO
|
Jun 30, 2022 |
S1 Ep52: Oncology Peer Review On-The-Go: Financial Conflicts of Interest Among Junior Faculty in Hematology and Oncology
|
Jun 27, 2022 |
S1 Ep51: Oncology Peer Review On-The-Go: Academic Promotion and Oncology Drug Development
|
Jun 20, 2022 |
S1 Ep25: Oncology Peer Review On-The-Go: Successful Diagnosis and Treatment of Occult Prostate Cancer Despite Multiple Negative Prostate Biopsies and Negative Prostate MRIs
|
May 30, 2022 |
S2 Ep25: Between the Lines™ Podcast: Updates in Use of Proteasome Inhibitors for Relapsed/Refractory Multiple Myeloma
|
May 20, 2022 |
S1 Ep49: Tanios Bekaii-Saab, MD, and Colleagues Discuss GOZILA Platform for CRC
|
May 16, 2022 |
S1 Ep50: Tanios Bekaii-Saab, MD, and Experts Examine Therapy Resistance in CRC
|
May 16, 2022 |
S1 Ep48: Tanios Bekaii-Saab, MD, Talks COLOMATE Platform for CRC With GI Experts
|
May 09, 2022 |
S2 Ep24: OncView™ Podcast: Advances in Systemic Therapy of Differentiated Thyroid Cancer
|
May 06, 2022 |
S2 Ep23: OncView™ Podcast: Safety and Efficacy of Available Treatment Options and Considerations for Patient Management in Metastatic RCC
|
Apr 29, 2022 |
S2 Ep22: Between the Lines™ Podcast: Mobocertinib Use in Platinum-Pretreated Patients With EGFR Exon 20 Insertion–Positive mNSCLC
|
Apr 27, 2022 |
S1 Ep47: Characterization of Blood-Based Molecular Profiling in Pancreatic Adenocarcinoma
|
Apr 25, 2022 |
S1 Ep46: PARP Inhibitors as Maintenance Therapy for Metastatic CRPC
|
Apr 11, 2022 |
S2 Ep21: OncView™ Podcast: EGFR Exon 20 Insertion as Therapeutic Target in NSCLC
|
Apr 08, 2022 |
S2 Ep20: Between the Lines™ Podcast: ctDNA as a Biomarker of Progression in Colorectal Cancer
|
Apr 05, 2022 |
S2 Ep19: OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
|
Apr 02, 2022 |
S2 Ep18: OncView™ Podcast: Immunotherapy Response Monitoring in Lung Cancer
|
Mar 30, 2022 |
S1 Ep45: Real-World Assessment of Care and Efficiency With Subcutaneous Rituximab
|
Mar 28, 2022 |
S1 Ep44: Neoadjuvant Chemotherapy for Elderly Patients with Muscle-Invasive Bladder Cancer
|
Mar 14, 2022 |
S1 Ep43: Ofer Sharon, MD, Discusses OncoHost and PROPHETIC Trial
|
Feb 28, 2022 |
S1 Ep42: Metastatic Basal Cell Carcinoma Arising From a Primary Cutaneous Carcinosarcoma
|
Feb 14, 2022 |
S1 Ep41: Matthew Allaway, DO, on Transperineal Biopsy Approach for Prostate Cancer
|
Jan 31, 2022 |
S1 Ep40: Amy Comander, MD, on SABCS and Key Breast Cancer Data from 2021
|
Jan 17, 2022 |
S2 Ep17: Between the Lines™ Podcast: Incorporating Real-World Evidence into Clinical Decisions in NSCLC
|
Jan 14, 2022 |
S1 Ep39: Improving Experience of LGBTQ+ Patients in Cancer Care
|
Jan 03, 2022 |
S2 Ep16: Future Directions in Small Cell Lung Cancer Treatment
|
Dec 22, 2021 |
S1 Ep38: Relationship Between Medical Oncologists and Genetic Counselors in Prostate Cancer
|
Dec 20, 2021 |
S2 Ep15: Practical Considerations for Small Cell Lung Cancer Therapeutic Options
|
Dec 16, 2021 |
S1 Ep37: Increasing Testing Access and Guiding Treatment Options with TrialJectory
|
Dec 06, 2021 |
S2 Ep14: Treatment Options for Relapsed/Refractory Small Cell Lung Cancer
|
Dec 02, 2021 |
S1 Ep36: Value of Geriatric Assessment in Patients With Genitourinary Carcinoma
|
Nov 22, 2021 |
S1 Ep35: Germline Testing in Prostate Cancer: When and Who to Test
|
Nov 08, 2021 |
S2 Ep13: First-Line Therapeutic Options in Small Cell Lung Cancer
|
Nov 01, 2021 |
S2 Ep12: OncView™ Podcast: Connie Batlevi, MD, PhD on R/R Follicular Lymphoma Therapy Updates
|
Oct 29, 2021 |
S1 Ep34: Debra Patt, MD, PhD, MBA, FASCO, on Telehealth in Cancer Care
|
Oct 25, 2021 |
S2 Ep11: Between the Lines: PET/CT-Guided Postprostatectomy Salvage Radiotherapy for Prostate Cancer
|
Oct 19, 2021 |
S1 Ep33: Plasma Glutamine as a Prognostic Biomarker in Localized Prostate Cancer
|
Oct 11, 2021 |
S1 Ep32: ScaleReady’s Work to Make Cell and Gene Therapy Practical and Viable
|
Sep 27, 2021 |
S1 Ep31: Inside the Advancing Inclusive Research Site Alliance for Clinical Trial Diversity
|
Sep 13, 2021 |
S2 Ep10: Two Experts Review Important R/R DLBCL Treatment Decisions and Data
|
Aug 30, 2021 |
S2 Ep9: OncView™ Podcast: Updates in Therapies of Relapsed/Refractory Follicular Lymphoma
|
Aug 25, 2021 |
S2 Ep8: OncView™ Podcast: NCCN Guideline Updates in HR+ Breast Cancer
|
Aug 20, 2021 |
S1 Ep30: Routine Breast Cancer Screening in Average-Risk Women Younger Than 50 Years
|
Aug 16, 2021 |
S1 Ep29: Examining Evidence Underlying the NCCN Guidelines for Hematologic Malignancies
|
Aug 02, 2021 |
S2 Ep7: Kami Maddocks, MD, on Rituximab Rechallenging and Second-Line Therapies for R/R DLBCL
|
Jul 30, 2021 |
S1 Ep28: Considering Second-Line Treatment Amidst Evolving Frontline Landscape for Clear Cell RCC
|
Jul 19, 2021 |
S2 Ep6: OncView™ Podcast: Updates in Managing Extensive-Stage Small Cell Lung Cancer
|
Jul 16, 2021 |
S1 Ep27: BPCIA, 4-Letter Suffix Rule, & the Challenges of Biosimilar Prescription
|
Jul 05, 2021 |
S2 Ep5: Emerging and Existing Treatment Regimens for Transplant-Ineligible DLBCL
|
Jun 30, 2021 |
S2 Ep4: OncView Podcast: Front-Line Management of Extensive-Stage SCLC
|
Jun 28, 2021 |
S1 Ep26: Molecular Profiling Practices in Pancreatic Adenocarcinoma
|
Jun 21, 2021 |
S2 Ep3: OncView™ Podcast: Management of Relapsed/Refractory Follicular Lymphoma
|
Jun 17, 2021 |
S1 Ep25: Primary Focal Therapy for Localized Prostate Cancer
|
Jun 07, 2021 |
S1 Ep24: Treatment Considerations for Transplant-Ineligible Multiple Myeloma
|
May 24, 2021 |
S2 Ep2: OncView Podcast: Optimizing Treatment With Extended Adjuvant Therapy for HR+ Breast Cancer
|
May 19, 2021 |
S2 Ep1: OncView Podcast: Genomic Testing in HR+ Breast Cancer to Guide Therapy in the Extended Adjuvant Setting
|
May 18, 2021 |
S1 Ep23: A Critical Interval to Delay Progression of Prostate Cancer
|
May 10, 2021 |
S1 Ep22: Integrating PARP Inhibitors Into Advanced Prostate Cancer Therapeutics
|
Apr 26, 2021 |
S1 Ep21: 1-on-1 with David Johnson: Enveric's Endocannabinoid Products for Glioblastoma
|
Apr 12, 2021 |
S1 Ep20: COVID-19, Cancer, and the Potential of mRNA Vaccines
|
Mar 29, 2021 |
S1 Ep19: Impact of Treatment Refusal on Survival for Small Cell Lung Cancer
|
Mar 15, 2021 |
S1 Ep18: 1-on-1 with Richard Schilsky, MD: Molecular Profiling in GI Cancers
|
Mar 01, 2021 |
S1 Ep17: Utility of 21-Gene Recurrence Score for Node-Positive Breast Cancer
|
Feb 15, 2021 |
S1 Ep16: Mediterranean Diet's Association with Localized Prostate Cancer
|
Feb 01, 2021 |
S1 Ep15: Guidelines for Palliative Treatment of Spinal Metastases
|
Jan 18, 2021 |
S1 Ep14: 1-on-1 with Che-Kai Tsao, MD: Smoking Cessation and Patient Screening
|
Jan 04, 2021 |
S1 Ep13: Recommending Patient-Reported Outcomes of Pain for Cancer Care
|
Dec 21, 2020 |
S1 Ep12: 1-on-1 with Zuri Murrell, MD: Colorectal Cancer in Black Patients
|
Dec 07, 2020 |
S1 Ep11: Fertility Preservation Decision-Making for Adolescents with Cancer
|
Nov 23, 2020 |
S1 Ep10: Barriers to Pancreatic Cancer Clinical Trial Enrollment
|
Nov 09, 2020 |
S1 Ep9: Cancer Care Management During the COVID-19 Pandemic
|
Oct 26, 2020 |
S1 Ep8: The Psychological Aspect of Patients in Phase 1 Clinical Trials
|
Oct 12, 2020 |
S1 Ep7: Molecular Profiling in Metastatic Colorectal Cancer
|
Sep 28, 2020 |
S1 Ep6: 1-on-1 with Dr. Michael Randell: New ACS Guidelines for Cervical Cancer
|
Sep 14, 2020 |
S1 Ep5: Is Next-Generation Sequencing a Right for Patients with GI Cancers?
|
Aug 31, 2020 |
S1 Ep4: The COVID-19 Pandemic's Impact on Cancer Screenings
|
Aug 17, 2020 |
S1 Ep3: Clinical Trials System and the COVID-19 Pandemic
|
Aug 03, 2020 |
S1 Ep2: 1-on-1 with Dr. Xu Ji: Mental Health Among Cancer Survivors
|
Jul 20, 2020 |
S1 Ep1: Minority Treatment Disparities and Clinical Trial Enrollment
|
Jul 06, 2020 |